Plascentra is OBH’s strategic venture focused on plasma-derived medicinal products (PDMPs). It addresses a critical regional gap by establishing the infrastructure for plasma collection, fractionation, and therapeutic production. This ensures self-sufficiency in life-saving treatments such as immunoglobulins, clotting factors, and albumin, reducing reliance on imports and creating long-term healthcare resilience.